The Role of Artificial Intelligence in Enhancing Insulin Recommendations and Therapy Outcomes
By: Maria Panagiotou , Knut Stroemmen , Lorenzo Brigato and more
Potential Business Impact:
Helps diabetes patients get the right insulin dose.
The growing worldwide incidence of diabetes requires more effective approaches for managing blood glucose levels. Insulin delivery systems have advanced significantly, with artificial intelligence (AI) playing a key role in improving their precision and adaptability. AI algorithms, particularly those based on reinforcement learning, allow for personalised insulin dosing by continuously adapting to an individual's responses. Despite these advancements, challenges such as data privacy, algorithm transparency, and accessibility still need to be addressed. Continued progress and validation in AI-driven insulin delivery systems promise to improve therapy outcomes further, offering people more effective and individualised management of their diabetes. This paper presents an overview of current strategies, key challenges, and future directions.
Similar Papers
Precise Insulin Delivery for Artificial Pancreas: A Reinforcement Learning Optimized Adaptive Fuzzy Control Approach
Systems and Control
Helps artificial pancreas keep blood sugar steady.
Limits of trust in medical AI
Machine Learning (CS)
AI can help doctors, but patients might not trust it.
Between Knowledge and Care: Evaluating Generative AI-Based IUI in Type 2 Diabetes Management Through Patient and Physician Perspectives
Human-Computer Interaction
AI gives health advice, but doctors say it's not safe.